Risk Factors of Metintas et al for Poor Prognosis in a Patient with Diffuse Malignant Pleural Mesothelioma

Description

Metintas et al identified a number of risk factors for poor prognosis in a patient with a diffuse malignant pleural mesothelioma. These can help identify a patient who may benefit from more aggressive management. The authors are from Osmangazi University in Eskisehir, Turkey, and Llandough Hospital in Cardiff, UK.

Parameters identified on multivariate analysis:

(1) age

(2) clinical tumor stage

(3) Karnofsky performance scale

(4) serum LDH

Parameter	Finding	Points
age of the patient	< 75 years	0
	>= 75 years of age	1
clinical tumor stage	I	0
	II, III, or IV	1
Karnofsky performance scale	>= 70	0
	< 70	1
serum LDH	< 500 IU/L	0
	>= 500 IU/L	1

where:

• The risk ratios ranged from 1.7 to 2.6.

total score =

= SUM(points for all 4 parameters)

Interpretation:

• minimum score: 0

• maximum score: 4

• The higher the score the greater the risk of a poor outcome.

Limitations:

• The authors did not specify the method, instrument or normal reference range for the serum LDH.

To read more or access our algorithms and calculators, please log in or register.

Risk Factors of Metintas et al for Poor Prognosis in a Patient with Diffuse Malignant Pleural Mesothelioma

Description

Specialty